Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 931Neoplasms 705Prostatic Neoplasms 487Lung Neoplasms 390Colorectal Neoplasms 359Carcinoma, Non-Small-Cell Lung 356Leukemia, Myeloid, Acute 278Pancreatic Neoplasms 233Brain Neoplasms 223Neoplasm Metastasis 221Multiple Myeloma 214Carcinoma, Hepatocellular 199Head and Neck Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 180Glioblastoma 180Melanoma 173Ovarian Neoplasms 167Squamous Cell Carcinoma of Head and Neck 158Recurrence 143Rectal Neoplasms 142Uterine Cervical Neoplasms 140Sarcoma 134Hematologic Neoplasms 131Glioma 128Stomach Neoplasms 127Triple Negative Breast Neoplasms 126Carcinoma, Renal Cell 123Esophageal Neoplasms 109Colonic Neoplasms 109Myelodysplastic Syndromes 107

Interventions

pegfilgrastim 1Gemcitabine 1Cystectomy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Infiltrating Bladder Urothelial Carcinoma × 90 days × Clear all
NCT03609216 2026-04-13

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
237 enrolled
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡